The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Ádám, D.,
Arany, J.,
Tóth, K. F.,
Pető, O.,
Nyitrai, T.,
Tóth, I. B.,
Póliska, S.,
Zouboulis, C. C.,
Oláh, A.:
The TRPM5 antagonist triphenylphosphine oxide (TPPO) increases sebaceous lipogenesis and modulates immune phenotype of human sebocytes in a TRPM5-independent manner.
Exp. Dermatol. 34 (5), 1-13, (article identifier: 70115), 2025.
Ádám, D.,
Arany, J.,
Tóth, K. F.,
Pető, O.,
Nyitrai, T.,
Tóth, I. B.,
Póliska, S.,
Zouboulis, C. C.,
Oláh, A.:
The TRPM5 antagonist triphenylphosphine oxide increases sebaceous lipogenesis and modulates immune phenotype of human sebocytes in a TRPM5-independent manner.
J. Invest. Dermatol. 144 (12_Suppl), S313, 2024.
Arany, J.,
Ádám, D.,
Cseszlai, M.,
Nyitrai, T.,
Zouboulis, C. C.,
Oláh, A.:
Adenosine receptors are novel regulators of human sebocyte biology.
J. Invest. Dermatol. 143 (Suppl_11), S355, 2023.
